Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival
By LabMedica International staff writers Posted on 06 Nov 2024 |
.jpg)
A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their surfaces, creating physical 'synapses' between cells. This movement of resources from within the cell to its surface is essential for coordinating immune responses against pathogens and cancers. To explore the interactions of immune cells within the tumor microenvironment—the area surrounding a tumor—researchers typically isolate these immune cells to analyze the genes active in each cell type. Alternatively, they may apply fluorescent tags to specific proteins and use microscopy to visualize the abundance of those proteins based on fluorescence intensity. However, neither method reveals whether the proteins are located on the cell surface at a synapse, contributing to cell-to-cell interactions. A new combination of imaging and computational techniques has now been developed to study the connections between immune cells in breast cancer and melanoma.
Researchers at The Jackson Laboratory (JAX, Bar Harbor, ME, USA) began by utilizing existing microscopy data to examine how signaling molecules cluster at immune synapses, providing a more comprehensive understanding of immune cell interactions. They went on to integrate advanced imaging methods with a novel computational technique to investigate immune cell interactions in unprecedented detail, discovering that these interactions in the context of breast cancer or melanoma can help predict immune responses and patient outcomes. Notably, the research indicated that increased interactions between two specific types of immune cells correlated with longer survival in breast cancer patients.
The technique, known as Computational Immune Synapse Analysis (CISA), allows the research team to detect not only which cells within a tissue contact each other physically but also whether key molecules are concentrated at those contact points. The method analyzes immune cell images, emphasizing cell edges and potential immune synapses, and compares these to the localization of tagged molecules. By focusing on T cells, the researchers demonstrated that CISA could identify interactions between T cells and other immune cells within tumor microenvironments in human melanoma samples. Additional experiments indicated that synapses formed between T cells and macrophages—cells that engulf pathogens and tumor cells—were associated with increased T cell proliferation.
The researchers then assessed whether immune cell interactions in breast cancer samples influenced the progression of the cancer. Their findings, published in the advanced online issue of Communications Biology, revealed that stronger connections between T cells and B cells—another immune cell type—were linked to improved survival rates for patients. This insight could eventually facilitate new methods for predicting patient outcomes, selecting candidates for immune therapies, or even developing novel immunotherapies. Identifying significant patterns in cell interactions is the ultimate aim of CISA. The researchers have made this image analysis platform accessible online for other scientists and believe it could be utilized to analyze interactions between various cell types. Additionally, it is capable of processing different types of images; melanoma samples were examined using histocytometry, while breast cancer samples were analyzed using imaging mass cytometry (IMC). The team plans to extend their method to other tumor types and immune cell types to deepen their understanding of the tumor microenvironment and its effects on cancer.
“Researchers have long suspected that better characterizing this complex community, which includes immune cells, blood vessels, and signaling molecules, could shed light on how cancers grow, spread, and respond to treatment,” said Jeffrey Chuang, a professor at JAX and senior author of the new study. “This new analysis lets us quantify the locations and interactions of cells and molecules in a way that has never before been possible using imaging.”
Latest Immunology News
- Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
- New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
- Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
- Novel Analytical Method Tracks Progression of Autoimmune Diseases
- 3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response
- Blood Test for Fungal Infections Could End Invasive Tissue Biopsies
- Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies
- New Discovery in Blood Immune Cells Paves Way for Parkinson's Disease Diagnostic Test
- AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Various Cancers
- Blood Test Can Predict How Long Vaccine Immunity Will Last
- Microfluidic Chip-Based Device to Measure Viral Immunity
- Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients
- Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients
- Biomarker Could Predict Immunotherapy Response in Liver Cancer
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more